Clinical Trial: A prospective, multicohort, randomized, open-label clinical study of neoadjuvant chemoradiotherapy with durvalumab in locally advanced resectable esophageal squamous cell carcinoma (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicohort, randomized, open-label clinical study of neoadjuvant chemoradiotherapy with durvalumab in locally advanced resectable esophageal squamous cell carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136222

Registration Time: 2026/11/07

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of He'nan University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346690

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective, multicohort, randomized, open-label clinical study of neoadjuvant chemoradiotherapy with durvalumab in locally advanced resectable esophageal squamous cell carcinoma (China)